Penn Davis McFarland’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.5M Sell
41,217
-127
-0.3% -$29.6K 0.93% 29
2026
Q1
$10.1M Sell
41,344
-81
-0.2% -$18.9K 0.99% 27
2025
Q4
$8.57M Sell
41,425
-115
-0.3% -$22.7K 0.82% 26
2025
Q3
$7.7M Hold
41,540
0.8% 26
2025
Q2
$6.35M Buy
41,540
+204
+0.5% +$31.4K 0.71% 27
2025
Q1
$6.86M Sell
41,336
-120
-0.3% -$18.8K 0.81% 27
2024
Q4
$6M Sell
41,456
-550
-1% -$85.2K 0.65% 29
2024
Q3
$6.81M Buy
+42,006
New +$6.69M 0.77% 28

Other funds holding JNJ

Penn Davis McFarland's JNJ Position: Q2 2026 in Review

Penn Davis McFarland reduced its Johnson & Johnson (JNJ) stake by 0.31% in Q2 2026, selling an estimated $29.6K and leaving 41,217 shares worth $10.5M. The position accounts for 0.93% of the portfolio, ranked #29.

Penn Davis McFarland first reported a position in JNJ in Q3 2024 and has held it in 8 quarters since. 899 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Penn Davis McFarland held 41,217 shares of Johnson & Johnson worth $10.5M as of Q2 2026.
  • Penn Davis McFarland sold 127 Johnson & Johnson shares in Q2 2026, an estimated $29.6K.
  • Johnson & Johnson made up 0.93% of Penn Davis McFarland's portfolio in Q2 2026, its #29 holding.
  • Penn Davis McFarland first reported a position in Johnson & Johnson in Q3 2024 and has held it in 8 quarters since.
  • 899 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Penn Davis McFarland's 13F filing for Q2 2026, filed 15 Jul 2026.